Cherry Creek Investment Advisors, Inc.

Position in PFE — Pfizer Inc

CIK 1877829 ENGLEWOOD, CO

Position in PFE

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$581,604

-$2,825 QoQ

Shares Held

24,153

+16.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.32%

of 13F equity value

Holder Rank

#1,648

of 2,821 holders

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Cherry Creek Investment Advisors, Inc. holds $9,772,035 across 6 Drug Manufacturers - General names. PFE ranks #3 (6.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	27,564	$6,936,204
2	GILD	Gilead Sciences, Inc.	8,954	$1,131,248
3	PFE	Pfizer Inc This page	24,153	$581,604
4	BMY	Bristol Myers Squibb Co	9,754	$562,025
5	JNJ	Johnson & Johnson	1,108	$281,398
6	AMGN	Amgen Inc	772	$279,556

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$581,604	24,153	+16.0%	Shares	Sole	2026-07-30
2026-03-31	$584,429	20,813	+1.6%	Shares	Sole	2026-04-30
2025-12-31	$510,001	20,482	-33.8%	Shares	Sole	2026-01-15
2023-09-30	$1,025,616	30,920	-1.4%	Shares	Sole	2023-10-13
2023-06-30	$1,150,724	31,372	+1.3%	Shares	Sole	2023-07-14
2023-03-31	$1,263,168	30,960	-0.7%	Shares	Sole	2023-04-24
2022-12-31	$1,597,099	31,169	+0.5%	Shares	Sole	2023-02-10
2022-09-30	$1,357,610	31,024	+0.9%	Shares	Sole	2022-10-24
2022-06-30	$1,612,641	30,758	-0.2%	Shares	Sole	2022-07-20
2022-03-31	$1,596,120	30,831	-0.9%	Shares	Sole	2022-04-22
2021-12-31	$1,837,990	31,126	+2.1%	Shares	Sole	2022-02-11
2021-09-30	$1,310,858	30,478	+11.0%	Shares	Sole	2021-11-01
2021-06-30	$1,075,725	27,470	—	Shares	Sole	2021-08-13
No filing history on record for this holder in this stock.